309 related articles for article (PubMed ID: 32323164)
1. Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma.
Viganò L; Lleo A; Muglia R; Gennaro N; Samà L; Colapietro F; Roncalli M; Aghemo A; Chiti A; Di Tommaso L; Solbiati L; Colombo M; Torzilli G
Updates Surg; 2020 Jun; 72(2):413-421. PubMed ID: 32323164
[TBL] [Abstract][Full Text] [Related]
2. Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma.
Li R; Cai P; Ma KS; Ding SY; Guo DY; Yan XC
Sci Rep; 2016 May; 6():26772. PubMed ID: 27226026
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
[TBL] [Abstract][Full Text] [Related]
4. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of Intrahepatic Cholangiocellular Carcinoma from Hepatocellular Carcinoma in the Cirrhotic Liver Using Contrast-enhanced MR Imaging.
Wengert GJ; Baltzer PAT; Bickel H; Thurner P; Breitenseher J; Lazar M; Pones M; Peck-Radosavljevic M; Hucke F; Ba-Ssalamah A
Acad Radiol; 2017 Dec; 24(12):1491-1500. PubMed ID: 28756085
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.
Bohle W; Clemens PU; Heubach T; Zoller WG
Ultraschall Med; 2012 Dec; 33(7):E191-E195. PubMed ID: 22194045
[TBL] [Abstract][Full Text] [Related]
7. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
8. Small intrahepatic peripheral cholangiocarcinomas as mimics of hepatocellular carcinoma in multiphasic CT.
Mendiratta-Lala M; Park H; Kolicaj N; Mendiratta V; Bassi D
Abdom Radiol (NY); 2017 Jan; 42(1):171-178. PubMed ID: 27590067
[TBL] [Abstract][Full Text] [Related]
9. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.
Dong Y; Chen S; Möller K; Qiu YJ; Lu XY; Zhang Q; Dietrich CF; Wang WP
Ultrasound Med Biol; 2023 Aug; 49(8):1780-1788. PubMed ID: 37156676
[TBL] [Abstract][Full Text] [Related]
10. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
11. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
Kim SJ; Lee JM; Han JK; Kim KH; Lee JY; Choi BI
AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
[TBL] [Abstract][Full Text] [Related]
12. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT.
Choi SH; Lee SS; Kim SY; Park SH; Park SH; Kim KM; Hong SM; Yu E; Lee MG
Radiology; 2017 Mar; 282(3):771-781. PubMed ID: 27797675
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
16. Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.
Li R; Yuan MX; Ma KS; Li XW; Tang CL; Zhang XH; Guo DY; Yan XC
PLoS One; 2014; 9(5):e98612. PubMed ID: 24874413
[TBL] [Abstract][Full Text] [Related]
17. Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.
Kim JH; Joo I; Lee JM
Korean J Radiol; 2019 Jul; 20(7):1019-1041. PubMed ID: 31270973
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma.
Jung AY; Lee JM; Choi SH; Kim SH; Lee JY; Kim SW; Han JK; Choi BI
J Comput Assist Tomogr; 2006; 30(1):18-24. PubMed ID: 16365567
[TBL] [Abstract][Full Text] [Related]
20. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.
Iavarone M; Piscaglia F; Vavassori S; Galassi M; Sangiovanni A; Venerandi L; Forzenigo LV; Golfieri R; Bolondi L; Colombo M
J Hepatol; 2013 Jun; 58(6):1188-93. PubMed ID: 23485522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]